Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin
Xuping Wu(Uppsala University), Simon Ekman(Uppsala University)
Cited by 61
Related Papers
Microtubule inhibition causes epidermal growth factor receptor inactivation in oesophageal cancer cells
|International Journal of Oncology|2012|19